CORRECTING and REPLACING CereTom-equipped Mobile Stroke Unit to be Featured at World’s Largest Gathering of Emergency Physicians

New Technology Enables Faster Treatment for Stroke Patients

BOSTON–(BUSINESS WIRE)–Please replace the release with the following corrected version due to
multiple revisions.


The corrected release reads:

CERETOM-EQUIPPED MOBILE STROKE UNIT TO BE FEATURED AT WORLD’S LARGEST
GATHERING OF EMERGENCY PHYSICIANS

New Technology Enables Faster Treatment for Stroke Patients

More than 7,500 emergency physicians will see the CereTom® CT (computed
tomography) mobile stroke unit (MSU) in action at this year’s American
College of Emergency Physicians (ACEP) Scientific Assembly taking place
in Boston from October 26 – 29. The MSU on display at ACEP15 was
co-developed by Stryker, Frazer and Samsung NeuroLogica.

A trending topic at this year’s ACEP meeting, stroke continues to be a
leading cause of death in the United States. A mobile stroke unit (MSU)
is a specialized emergency medical vehicle that can help diagnose stroke
in patients, as well as identify ischemic vs. hemorrhagic strokes. The
CereTom CT scanner is a critical element of the process. For many stroke
patients, time is critical for administering treatment that can prevent
or minimize brain injury, and MSU teams can act on diagnostic tests
right there in the vehicle. Last year the University of Texas Health
Science Center at Houston (UTHealth) Medical School debuted the nation’s
first MSU, in partnership with Memorial Hermann-Texas Medical Center,
CHI St. Luke’s Hospital and Houston Methodist Hospital. There are
currently four active mobile stroke unit programs in the US, and
interest is growing from both academic and non-academic medical centers.

“It typically takes roughly an hour once a stroke patient arrives in the
emergency room to receive treatment. With the mobile stroke unit, we can
actually put the emergency room in the ambulance, take the CT scanner to
the patient and treat at the scene with the medication, saving that
hour,” said James C. Grotta, M.D., director of a multi-institutional
consortium of participating partners in the UTHealth Mobile Stroke Unit.
“And, that hour could mean saving 120 million brain cells.”

The CereTom is an 8-slice, portable CT scanner that delivers
high-quality scans in a variety of patient locations. Its combination of
rapid scan time, easy-to-use interface and immediate image viewing make
CereTom an indispensable tool for any clinician needing real-time,
high-quality images. It is optimized for use in a variety of settings
including the MSU, ICU, NICU, emergency department and in patient rooms.
For stroke patients, the CereTom-based MSU has proven to reduce
time-to-treatment for patients,i as well as hospital length
of stay.ii

Stroke kills nearly 130,000 Americans each year, accounting for one of
every 20 deaths, or one person every four minutes. Of the approximate
800,000 Americans that have a stroke annually, about 87% are ischemic.iii
Thankfully, ischemic strokes can be treated with a tissue
plasminogen activator (tPA), a drug that—if administered within three
hours of the first signs of stroke—has the potential to dissolve the
clot to improve blood flow back in the affected part of the brain. It
has become the standard of care for ischemic stroke.

“There is a tremendous amount of pressure on emergency physicians to
deliver quick and effective care for patients, especially when it comes
to ischemic stroke,” said Philip Sullivan, Samsung NeuroLogica president
and CEO. “When given tools like the CereTom CT, we see the innovation
and advancements like those at UTHealth, paving the way to establishing
a new standard of care.”

Stroke-treatment educational sessions on the ACEP15 program include: CT
angiography (CTA), CT perfusion (CTP) and MR scanning for stroke
evaluation (MO-19); legal risk of stroke cases (MO-54); practical
considerations for administering tPA for ischemic stroke (TU-79); stroke
care for runners on road race days (TU-102); new research on stroke
patient management (TU-136); evidence-based approaches to intercranial
hemorrhage (WE-280); and how to interpret conflicting guidelines for
interpreting a patient’s blood pressure stats during stroke treatment
(TH-313).

To schedule a time to see the CereTom CT mobile stroke unit (MSU) in
action, contact Lynne Gagne at lgagne@neurologica.com.
The MSU will be on display for the duration of ACEP15 taking place
October 26-29 at the Boston Convention & Exhibition Center. A UTHealth
MSU team member will be on-site and available to answer questions about
this cutting-edge stroke treatment strategy.

About UTHealth

Established in 1972 by The
University of Texas System Board of Regents
, The University of Texas
Health Science Center at Houston (UTHealth) is Houston’s Health
University and Texas’ resource for health care education, innovation,
scientific discovery and excellence in patient care. The most
comprehensive academic health center in The
UT System
 and the U.S. Gulf Coast region, UTHealth is home to
schools of biomedical
informatics
biomedical
sciences
dentistrymedicinenursing and public
health
 and includes The
University of Texas Harris County Psychiatric Center
 and a growing
network of clinics
 throughout the region. The university’s primary
teaching hospitals include Memorial
Hermann-Texas Medical Center
Children’s
Memorial Hermann Hospital
 and Harris
Health Lyndon B. Johnson Hospital
. For more information, visit www.uth.edu.

About NeuroLogica

NeuroLogica, the healthcare subsidiary of Samsung Electronics Co., Ltd.,
develops, manufactures, and markets innovative imaging technologies and
is committed to delivering fast, easy and accurate diagnostic solutions
to healthcare providers. NeuroLogica, the global corporate headquarters
and manufacturer of computed tomography, is also the U.S. headquarters
for sales, marketing and distribution of all Samsung digital radiography
and ultrasound systems. NeuroLogica’s growing portfolio of advanced
medical technologies are used worldwide in leading healthcare
institutions helping providers enhance patient care, improve patient
satisfaction, and increase workflow efficiency. Samsung is committed to
being leaders in the field of healthcare imaging. For more information,
please visit www.SamsungNeuroLogica.com.

About Samsung Electronics Co., Ltd.

Samsung Electronics Co., Ltd. inspires the world and shapes the future
with transformative ideas and technologies, redefining the worlds of
TVs, smartphones, wearable devices, tablets, cameras, digital
appliances, printers, medical equipment, network systems, and
semiconductor and LED solutions. We are also leading in the Internet of
Things space through, among others, our Smart Home and Digital Health
initiatives. We employ 307,000 people across 84 countries with annual
sales of US $196 billion. To discover more, please visit our official
website at www.samsung.com/
and our official blog at global.samsungtomorrow.com.

i Hussain MS et al. Abstract 54. Presented at: International
Stroke Conference 2015; Feb. 11-13, 2015; Nashville, Tennessee

ii Crit Care Clin 31 (2015) 197–224

iii CDC, NCHS. Underlying Cause of Death 1999-2013 on CDC
WONDER Online Database
, released 2015. Data are from the Multiple
Cause of Death Files, 1999-2013, as compiled from data provided by the
57 vital statistics jurisdictions through the Vital Statistics
Cooperative Program.

Contacts

Media Inquiries
NeuroLogica Corporation
Lynne Gagne,
978-564-8576
lgagne@neurologica.com